Beta-blockers in chronic heart failure: what have we learned? What do we still need to know?

No abstract is available for this paper.

• Publication year

  2003

• Venue

  Current opinion in pharmacology (Print)

• Publication date

  2003-04-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/S1471-4892(03)00008-0PMID 12681239
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Beta-adrenoceptor blockers in chronic heart failure--a review.

  2003cited by this paper
• Management of arrhythmias in heart failure.

  2003cited by this paper
• Rationale and design of the carvedilol or metoprolol European trial in patients with chronic heart failure: COMET

  2002cited by this paper
• Effects of Sustained-Release Moxonidine, an Imidazoline Agonist, on Plasma Norepinephrine in Patients With Chronic Heart Failure

  2002cited by this paper
• Study of the Effects of Nebivolol Intervention on Outcomes and Rehospitalisation in Seniors with Heart Failure (SENIORS). Rationale and design.

  2002cited by this paper
• Comparison of Omapatrilat and Enalapril in Patients With Chronic Heart Failure: The Omapatrilat Versus Enalapril Randomized Trial of Utility in Reducing Events (OVERTURE)

  2002cited by this paper
• Clinical trials update from the European Society of Cardiology: CARMEN, EARTH, OPTIMAAL, ACE, TEN‐HMS, MAGIC, SOLVD‐X and PATH‐CHF II

  2002cited by this paper
• Tumor necrosis factor-alpha blockade as a therapeutic strategy in heart failure (RENEWAL and ATTACH): unsuccessful, to be specific.

  2002cited by this paper
• Bucindolol Displays Intrinsic Sympathomimetic Activity in Human Myocardium

  2002cited by this paper
• Metoprolol CR/XL in Female Patients With Heart Failure: Analysis of the Experience in Metoprolol Extended-Release Randomized Intervention Trial in Heart Failure (MERIT-HF)

  2002cited by this paper
• Effects of losartan and captopril on mortality and morbidity in high-risk patients after acute myocardial infarction: the OPTIMAAL randomised trial. Optimal Trial in Myocardial Infarction with Angiotensin II Antagonist Losartan.

  2002cited by this paper
• Cardiac resynchronization in chronic heart failure.

  2002cited by this paper
• Tolerability of &bgr;-Blocker Initiation and Titration in the Metoprolol CR/XL Randomized Intervention Trial in Congestive Heart Failure (MERIT-HF)

  2002cited by this paper
• Dose of metoprolol CR/XL and clinical outcomes in patients with heart failure: analysis of the experience in metoprolol CR/XL randomized intervention trial in chronic heart failure (MERIT-HF).

  2002cited by this paper
• Clinical trials update: highlights of the scientific sessions of The American College of Cardiology 2002: LIFE, DANAMI 2, MADIT‐2, MIRACLE‐ICD, OVERTURE, OCTAVE, ENABLE 1 & 2, CHRISTMAS, AFFIRM, RACE, WIZARD, AZACS, REMATCH, BNP trial and HARDBALL

  2002cited by this paper
• Adenovirus-Mediated Gene Transfer of VEGF121 Improves Lower-Extremity Endothelial Function and Flow Reserve

  2001cited by this paper
• Pharmacogenetic Interactions Between &bgr;-Blocker Therapy and the Angiotensin-Converting Enzyme Deletion Polymorphism in Patients With Congestive Heart Failure

  2001cited by this paper
• Race and the response to adrenergic blockade with carvedilol in patients with chronic heart failure.

  2001cited by this paper
• A trial of the beta-blocker bucindolol in patients with advanced chronic heart failure.

  2001cited by this paper
• Neovascularization of ischemic myocardium by human bone-marrow–derived angioblasts prevents cardiomyocyte apoptosis, reduces remodeling and improves cardiac function

  2001cited by this paper
• Effect of carvedilol on outcome after myocardial infarction in patients with left-ventricular dysfunction: the CAPRICORN randomised trial.

  2001cited by this paper
• Effect of carvedilol on survival in severe chronic heart failure.

  2001cited by this paper
• A randomized trial of the angiotensin-receptor blocker valsartan in chronic heart failure.

  2001cited by this paper
• Heart Rate and Cardiac Rhythm Relationships With Bisoprolol Benefit in Chronic Heart Failure in CIBIS II Trial

  2001cited by this paper
• Effects of controlled-release metoprolol on total mortality, hospitalizations, and well-being in patients with heart failure: the Metoprolol CR/XL Randomized Intervention Trial in congestive heart failure (MERIT-HF). MERIT-HF Study Group.

  2000cited by this paper
• Genes and acquired disease: beta-adrenoceptor polymorphisms and heart failure.

  2000cited by this paper
• Effects of Controlled-Release Metoprolol on Total Mortality, Hospitalizations, and Well-being in Patients with Heart Failure: The Metoprolol CR/XL Randomized Intervention Trial in Congestive Heart Failure (MERIT-HF)

  2000cited by this paper
• Enhancing cardiac protection after myocardial infarction: rationale for newer clinical trials of angiotensin receptor blockers.

  2000cited by this paper
• Age-dependent cardiomyopathy and heart failure phenotype in mice overexpressing beta(2)-adrenergic receptors in the heart.

  2000cited by this paper
• Effect of losartan compared with captopril on mortality in patients with symptomatic heart failure: randomised trial--the Losartan Heart Failure Survival Study ELITE II.

  2000cited by this paper
• Candesartan in heart failure--assessment of reduction in mortality and morbidity (CHARM): rationale and design. Charm-Programme Investigators.

  1999cited by this paper
• Randomised, placebo-controlled trial of carvedilol in patients with congestive heart failure due to ischaemic heart disease. Australia/New Zealand Heart Failure Research Collaborative Group.

  1997cited by this paper
• The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. U.S. Carvedilol Heart Failure Study Group.

  1996cited by this paper
• A randomized trial of beta-blockade in heart failure. The Cardiac Insufficiency Bisoprolol Study (CIBIS). CIBIS Investigators and Committees.

  1994cited by this paper
• Beneficial effects of metoprolol in idiopathic dilated cardiomyopathy. Metoprolol in Dilated Cardiomyopathy (MDC) Trial Study Group.

  1993cited by this paper
• Neurohumoral activation in preclinical heart failure. Remodeling and the potential for intervention.

  1993cited by this paper
• Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure.

  1991cited by this paper

• Title: Effectiveness of -blockade in experimental chronic aortic regurgitation Plante et al.: -blockade in chronic aortic regurgitation

  2017cites this paper
• Third-generation beta-adrenoceptor antagonists in the treatment of hypertension and heart failure.

  2015cites this paper
• Modeling the Effects of β1-Adrenergic Receptor Blockers and Polymorphisms on Cardiac Myocyte Ca2+ Handling

  2014cites this paper
• Modeling the Effects of b 1-Adrenergic Receptor Blockers and Polymorphisms on Cardiac Myocyte Ca 2 1 Handling s

  2014cites this paper
• The effects of newer beta-adrenoceptor antagonists on vascular function in cardiovascular disease.

  2012cites this paper
• A self-controlled case series to assess the effectiveness of beta blockers for heart failure in reducing hospitalisations in the elderly

  2011cites this paper
• Effectiveness of -Blockade in Experimental Chronic Aortic Regurgitation

  2004cites this paper
• Effectiveness of beta-blockade in experimental chronic aortic regurgitation.

  2004cites this paper
• Effectiveness of &bgr;-Blockade in Experimental Chronic Aortic Regurgitation

  2004cites this paper
• Cardioselective Beta‐Blockers in Patients with Asthma and Concomitant Heart Failure or History of Myocardial Infarction: When Do Benefits Outweigh Risks?

  2003cites this paper
• Comparative pharmacology of human β-adrenergic receptor subtypes—characterization of stably transfected receptors in CHO cells

  2003cites this paper